Ole Henrik Eriksen

Ole Henrik Eriksen is a seasoned executive with extensive experience in business development and operations within the healthcare and pharmaceutical sectors. Currently serving as Chief Business Development Officer at Navamedic ASA since January 2019, Eriksen previously held the position of Chief Operating Officer and Founder at Novicus Pharma AS, and Chief Operating Officer at Weifa AS. Eriksen also contributed to companies such as Genetic Analysis AS as Chairman of the Board and Aqualis ASA as Chief Business Officer for Healthcare. With a significant tenure at Clavis Pharma ASA, Eriksen played a pivotal role as the first CEO and later as Chief Operating Officer. Educational credentials include a Master of Science in Organic Chemistry from the Norwegian University of Science and Technology (NTNU).